Product NDC: | 68788-9862 |
Proprietary Name: | Terazosin hydrochloride |
Non Proprietary Name: | Terazosin hydrochloride |
Active Ingredient(s): | 2 mg/1 & nbsp; Terazosin hydrochloride |
Administration Route(s): | ORAL |
Dosage Form(s): | CAPSULE |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 68788-9862 |
Labeler Name: | Preferred Pharmaceuticals, Inc |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA075317 |
Marketing Category: | ANDA |
Start Marketing Date: | 20120228 |
Package NDC: | 68788-9862-6 |
Package Description: | 60 CAPSULE in 1 BOTTLE (68788-9862-6) |
NDC Code | 68788-9862-6 |
Proprietary Name | Terazosin hydrochloride |
Package Description | 60 CAPSULE in 1 BOTTLE (68788-9862-6) |
Product NDC | 68788-9862 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Terazosin hydrochloride |
Dosage Form Name | CAPSULE |
Route Name | ORAL |
Start Marketing Date | 20120228 |
Marketing Category Name | ANDA |
Labeler Name | Preferred Pharmaceuticals, Inc |
Substance Name | TERAZOSIN HYDROCHLORIDE |
Strength Number | 2 |
Strength Unit | mg/1 |
Pharmaceutical Classes | Adrenergic alpha-Antagonists [MoA],alpha-Adrenergic Blocker [EPC] |